Tenaya Therapeutics, Inc. (TNYA) stock
TNYANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.32−0.01 (-3.24%)
Close on Nov 17, 2026Market cap $72.38MP/E –Yield –
Tenaya Therapeutics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Tenaya Therapeutics's ebitda for the twelve months ending Jun 30, 2026 was -$98.67M. For fiscal 2025 it was -$84.90M. The highest annual figure on record is -$36.43M in fiscal 2020.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$84.90M | – |
| FY2024 | Dec 31, 2024 | -$107.48M | – |
| FY2023 | Dec 31, 2023 | -$122.51M | – |
| FY2022 | Dec 31, 2022 | -$119.15M | – |
| FY2021 | Dec 31, 2021 | -$69.85M | – |
| FY2020 | Dec 31, 2020 | -$36.43M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$42.39M | – |
| Q1 FY2026 | Mar 31, 2026 | -$18.30M | – |
| Q4 FY2025 | Dec 31, 2025 | -$18.95M | – |
| Q3 FY2025 | Sep 30, 2025 | -$19.04M | – |
| Q2 FY2025 | Jun 30, 2025 | -$21.98M | – |
| Q1 FY2025 | Mar 31, 2025 | -$24.88M | – |
| Q4 FY2024 | Dec 31, 2024 | -$22.56M | – |
| Q3 FY2024 | Sep 30, 2024 | -$24.61M | – |
| Q2 FY2024 | Jun 30, 2024 | -$28.72M | – |
| Q1 FY2024 | Mar 31, 2024 | -$31.61M | – |
| Q4 FY2023 | Dec 31, 2023 | -$29.27M | – |
| Q3 FY2023 | Sep 30, 2023 | -$28.72M | – |
| Q2 FY2023 | Jun 30, 2023 | -$32.90M | – |
| Q1 FY2023 | Mar 31, 2023 | -$31.59M | – |
| Q4 FY2022 | Dec 31, 2022 | -$32.43M | – |
| Q3 FY2022 | Sep 30, 2022 | -$29.20M | – |
| Q2 FY2022 | Jun 30, 2022 | -$27.32M | – |
| Q1 FY2022 | Mar 31, 2022 | -$30.19M | – |
| Q4 FY2021 | Dec 31, 2021 | -$25.37M | – |
| Q3 FY2021 | Sep 30, 2021 | -$17.60M | – |
| Q2 FY2021 | Jun 30, 2021 | -$14.54M | – |
| Q1 FY2021 | Mar 31, 2021 | -$12.42M | – |
| Q4 FY2020 | Dec 31, 2020 | -$9.66M | – |
| Q3 FY2020 | Sep 30, 2020 | -$9.85M | – |
| Q2 FY2020 | Jun 30, 2020 | -$8.27M | – |
See a number that looks wrong?